Cargando…

92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens

BACKGROUND: Cytotoxic T lymphocyte associated gene-4 (CTLA-4) is involved in the activation pathways of T lymphocytes. It has been shown that the circulating form of CTLA-4 is elevated in patients with hymenoptera allergy and can be downregulated by immunotherapy. We assessed the effects on CTLA4 of...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccio, Anna Maria, Saverino, Daniele, Rogkakou, Anthi, Bagnasco, Marcello, Bonadonna, Patrizia, Canonica, Giorgio Walter, Ridolo, Erminia, Severino, Maurizio, Pesce, Giampaola, Passalacqua, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512746/
http://dx.doi.org/10.1097/01.WOX.0000411837.07871.9b
_version_ 1782251792241786880
author Riccio, Anna Maria
Saverino, Daniele
Rogkakou, Anthi
Bagnasco, Marcello
Bonadonna, Patrizia
Canonica, Giorgio Walter
Ridolo, Erminia
Severino, Maurizio
Pesce, Giampaola
Passalacqua, Giovanni
author_facet Riccio, Anna Maria
Saverino, Daniele
Rogkakou, Anthi
Bagnasco, Marcello
Bonadonna, Patrizia
Canonica, Giorgio Walter
Ridolo, Erminia
Severino, Maurizio
Pesce, Giampaola
Passalacqua, Giovanni
author_sort Riccio, Anna Maria
collection PubMed
description BACKGROUND: Cytotoxic T lymphocyte associated gene-4 (CTLA-4) is involved in the activation pathways of T lymphocytes. It has been shown that the circulating form of CTLA-4 is elevated in patients with hymenoptera allergy and can be downregulated by immunotherapy. We assessed the effects on CTLA4 of venom immunotherapy given by different induction protocols (classic, rush or ultra rush). METHODS: Sera from patients with hymenoptera allergy were collected at baseline and at the end of the induction phase. In the classical regimen, the induction lasted 6 weeks, in the rush protocol it lasted 3 days, and in the ultra-rush maintenance was achieved in 24 hours. Soluble IL-10 was assayed in the same samples for comparison. CTLA-4 and IL10 were measured by commercial immuoassays. RESULTS: Seventy-six patients (52 male, mean age 35 years) were studied. Of them, 30 underwent the classic induction, 22 the rush and 24 the ultra rush. Soluble CTLA-4 was detectable in all patients at baseline, and significantly decreased at the end of the induction in all groups, thus irrespective of its duration. Of note, a significant decrease of sCTLA-4 could be seen already at 24 hours. In parallel, the same behaviour was observed with IL-10 that significantly increased at the end of the induction. CONCLUSIONS: Soluble CTLA-4 is a useful immunological marker of the effect of immunotherapy for hymenoptera allergy. From an immunologic point of view, there is no difference among the various protocol of induction.
format Online
Article
Text
id pubmed-3512746
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35127462012-12-21 92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens Riccio, Anna Maria Saverino, Daniele Rogkakou, Anthi Bagnasco, Marcello Bonadonna, Patrizia Canonica, Giorgio Walter Ridolo, Erminia Severino, Maurizio Pesce, Giampaola Passalacqua, Giovanni World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Cytotoxic T lymphocyte associated gene-4 (CTLA-4) is involved in the activation pathways of T lymphocytes. It has been shown that the circulating form of CTLA-4 is elevated in patients with hymenoptera allergy and can be downregulated by immunotherapy. We assessed the effects on CTLA4 of venom immunotherapy given by different induction protocols (classic, rush or ultra rush). METHODS: Sera from patients with hymenoptera allergy were collected at baseline and at the end of the induction phase. In the classical regimen, the induction lasted 6 weeks, in the rush protocol it lasted 3 days, and in the ultra-rush maintenance was achieved in 24 hours. Soluble IL-10 was assayed in the same samples for comparison. CTLA-4 and IL10 were measured by commercial immuoassays. RESULTS: Seventy-six patients (52 male, mean age 35 years) were studied. Of them, 30 underwent the classic induction, 22 the rush and 24 the ultra rush. Soluble CTLA-4 was detectable in all patients at baseline, and significantly decreased at the end of the induction in all groups, thus irrespective of its duration. Of note, a significant decrease of sCTLA-4 could be seen already at 24 hours. In parallel, the same behaviour was observed with IL-10 that significantly increased at the end of the induction. CONCLUSIONS: Soluble CTLA-4 is a useful immunological marker of the effect of immunotherapy for hymenoptera allergy. From an immunologic point of view, there is no difference among the various protocol of induction. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512746/ http://dx.doi.org/10.1097/01.WOX.0000411837.07871.9b Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Riccio, Anna Maria
Saverino, Daniele
Rogkakou, Anthi
Bagnasco, Marcello
Bonadonna, Patrizia
Canonica, Giorgio Walter
Ridolo, Erminia
Severino, Maurizio
Pesce, Giampaola
Passalacqua, Giovanni
92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens
title 92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens
title_full 92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens
title_fullStr 92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens
title_full_unstemmed 92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens
title_short 92 Serum CTLA-4 AND IL-10 in Hymenoptera Venom Immunotherapy: Equivalence of Different Induction Regimens
title_sort 92 serum ctla-4 and il-10 in hymenoptera venom immunotherapy: equivalence of different induction regimens
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512746/
http://dx.doi.org/10.1097/01.WOX.0000411837.07871.9b
work_keys_str_mv AT riccioannamaria 92serumctla4andil10inhymenopteravenomimmunotherapyequivalenceofdifferentinductionregimens
AT saverinodaniele 92serumctla4andil10inhymenopteravenomimmunotherapyequivalenceofdifferentinductionregimens
AT rogkakouanthi 92serumctla4andil10inhymenopteravenomimmunotherapyequivalenceofdifferentinductionregimens
AT bagnascomarcello 92serumctla4andil10inhymenopteravenomimmunotherapyequivalenceofdifferentinductionregimens
AT bonadonnapatrizia 92serumctla4andil10inhymenopteravenomimmunotherapyequivalenceofdifferentinductionregimens
AT canonicagiorgiowalter 92serumctla4andil10inhymenopteravenomimmunotherapyequivalenceofdifferentinductionregimens
AT ridoloerminia 92serumctla4andil10inhymenopteravenomimmunotherapyequivalenceofdifferentinductionregimens
AT severinomaurizio 92serumctla4andil10inhymenopteravenomimmunotherapyequivalenceofdifferentinductionregimens
AT pescegiampaola 92serumctla4andil10inhymenopteravenomimmunotherapyequivalenceofdifferentinductionregimens
AT passalacquagiovanni 92serumctla4andil10inhymenopteravenomimmunotherapyequivalenceofdifferentinductionregimens